Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02122341 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of BackStop in Patients Undergoing Ureteroscopic Lithotripsy
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02122341 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 35 participants.
The verdict
NCT02122341, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to evaluate BackStop, a polymer-based device that is intended to be used during ureteroscopic lithotripsy to prevent retrograde stone migration.
Interventions
- DEVICE BackStop
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02122341
The ClinicalTrials.gov registry entry for NCT02122341 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BackStop is the first listed.
NCT02122341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02122341 about?
NCT02122341 is a clinical study titled "Clinical Evaluation of BackStop in Patients Undergoing Ureteroscopic Lithotripsy". The purpose of this clinical study is to evaluate BackStop, a polymer-based device that is intended to be used during ureteroscopic lithotripsy to prevent retrograde stone migration.
What is the current status of trial NCT02122341?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2014-04. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02122341?
The interventions under investigation include: BackStop (DEVICE).
Who is sponsoring clinical trial NCT02122341?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.